Metabolic active peritoneal sites affect tumor debulking in ovarian and peritoneal cancers
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Ovarian Research"
DOI: 10.1186/s13048-020-00662-3
Abstract: Rationale and objectives To evaluate the impact of metabolic parameters in the peritoneal cavity on the likelihood of achieving complete tumor debulking in patients with ovarian and peritoneal cancers. Materials and methods Forty-nine patients with… read more here.
Keywords: tumor debulking; ovarian peritoneal; peritoneal cancers; peritoneal sites ... See more keywords
Is liquid biopsy useful in patients with GI malignancies and exclusive peritoneal disease?
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2023.41.4_suppl.809
Abstract: 809 Background: Peritoneal carcinomatosis (PC) is a common manifestation in gastro-intestinal (GI) cancers.10-20 % of patients (pts) will present isolated, unresectable peritoneal disease with poor prognosis. In the past years, circulating tumor DNA (ctDNA) has… read more here.
Keywords: disease; peritoneal cancers; primary peritoneal; liquid ... See more keywords
Reclassification of BRCA1 and BRCA2 variants found in ovarian epithelial, fallopian tube, and primary peritoneal cancers
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Gynecologic Oncology"
DOI: 10.3802/jgo.2020.31.e83
Abstract: Objective We investigated the proportions of and reclassified BRCA1/2 variants of unknown significance (VUS) in Korean patients with epithelial ovarian, tubal, and primary peritoneal cancers. Methods Data from 805 patients who underwent genetic testing for… read more here.
Keywords: benign likely; 805 patients; vus; brca1 ... See more keywords